TMO FY 2018 Earnings Report — Thermo Fisher Scientific Inc. Revenue & Financial Results | Market Cap Arena

Thermo Fisher Scientific Inc.TMO

FY 2018 Earnings

Reported February 27, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2018	Prior Q	FY 2017	QoQ Change	YoY Change
Revenue	$24.4B	—	$20.9B	—	16.4%
Op. Income	$3.9B	—	$3.3B	—	18.5%
Gross Margin	45.1%	—	46.3%	—	-1.2pp
Net Margin	12.1%	—	10.6%	—	1.4pp
EPS (Diluted)	$7.24	—	$5.59	—	29.5%
Free Cash Flow	$3.8B	—	$3.5B	—	8.2%

Revenue Flow

Item	Amount
REVENUE	$24.4B
Cost of Revenue	$13.4B
GROSS PROFIT	$11.0B
R&D Expenses	$967M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$6.0B
Other Expenses	$121M
Operating Expenses	$7.1B
Cost & Expenses	$20.5B
OPERATING INCOME	$3.9B
Interest Income	$137M
Interest Expense	$667M
Other Income/Expenses	-$610M
INCOME BEFORE TAX	$3.3B
Income Tax Expense	$324M
Net Income from Continuing Ops	$2.9B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$2.9B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$2.9B
D&A	$2.3B
EBIT	$3.9B
EBITDA	$6.2B
EPS	$7
EPS Diluted	$7

Income Statement

Item	Amount
REVENUE	$24.4B
Cost of Revenue	$13.4B
GROSS PROFIT	$11.0B
R&D Expenses	$967M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$6.0B
Other Expenses	$121M
Operating Expenses	$7.1B
Cost & Expenses	$20.5B
OPERATING INCOME	$3.9B
Interest Income	$137M
Interest Expense	$667M
Other Income/Expenses	-$610M
INCOME BEFORE TAX	$3.3B
Income Tax Expense	$324M
Net Income from Continuing Ops	$2.9B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$2.9B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$2.9B
D&A	$2.3B
EBIT	$3.9B
EBITDA	$6.2B
EPS	$7
EPS Diluted	$7

Cash Flow Statement

Item	Amount
Net Income	$2.9B
Depreciation & Amortization	$2.3B
Stock-Based Compensation	$181M
Deferred Income Tax	-$419M
Other Non-Cash Items	$106M
Change in Working Capital	-$530M
OPERATING CASH FLOW	$4.5B
Capital Expenditure	-$758M
Acquisitions (Net)	-$536M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$41M
NET CASH FROM INVESTING	-$1.3B
Net Debt Issuance	-$1.6B
Common Stock Repurchased	-$500M
Common Dividends Paid	-$266M
Other Financing Activities	$85M
NET CASH FROM FINANCING	-$2.2B
FREE CASH FLOW	$3.8B
Net Change in Cash	$756M

Balance Sheet

Item	Amount
Cash & Equivalents	$2.1B
Short-Term Investments	$0
Net Receivables	$4.6B
Inventory	$3.0B
Other Current Assets	$922M
TOTAL CURRENT ASSETS	$10.6B
PP&E (Net)	$4.2B
Goodwill	$25.3B
Intangible Assets	$15.0B
Long-Term Investments	$53M
Tax Assets	$0
Other Non-Current Assets	$1.1B
TOTAL NON-CURRENT ASSETS	$45.6B
TOTAL ASSETS	$56.2B
Account Payables	$1.6B
Short-Term Debt	$1.3B
Deferred Revenue	$809M
Other Current Liabilities	$1.5B
TOTAL CURRENT LIABILITIES	$6.1B
Long-Term Debt	$17.7B
Deferred Revenue NC	$355M
Deferred Tax Liabilities	$2.3B
Other Non-Current Liabilities	$2.2B
TOTAL NON-CURRENT LIABILITIES	$22.5B
TOTAL LIABILITIES	$28.6B
Common Stock	$432M
Additional Paid-In Capital	$14.6B
Retained Earnings	$18.7B
Treasury Stock	-$3.7B
Accum. Other Comp. Income	-$2.5B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$27.6B
Minority Interest	$0
TOTAL EQUITY	$27.6B
TOTAL LIABILITIES & EQUITY	$56.2B
Total Debt	$19.0B
Net Debt	$16.9B